Alexander Valvezan is an Assistant Professor of Pharmacology at the Rutgers Robert Wood Johnson Medical School and Resident Faculty Member in the Center for Advanced Biotechnology and Medicine. Dr. Valvezan completed his PhD at the University of Pennsylvania in the laboratory of Dr. Peter Klein, studying the Wnt signaling pathway in embryonic development and cancer. He then joined the laboratory of Dr. Brendan Manning at Harvard University as a postdoctoral fellow, studying tumor metabolism and the mTOR signaling and metabolic network. Dr. Valvezan’s current research interests focus on understanding how signaling pathways coordinate metabolic networks to promote cell growth, with emphasis on the impact of common oncogenic mutations, and the goal of exploiting unique tumor dependencies for therapeutic benefit.
Assistant Professor of Pharmacology, RWJMS
Assistant Professor of Medicine, RWJMS
2020 Rutgers Cancer Institute of New Jersey New Investigator Award
Department of Defense Tuberous Sclerosis Complex Research Program Award